1060 related articles for article (PubMed ID: 19578112)
21. Lupus disease activity and the risk of subsequent organ damage and mortality in a large lupus cohort.
Lopez R; Davidson JE; Beeby MD; Egger PJ; Isenberg DA
Rheumatology (Oxford); 2012 Mar; 51(3):491-8. PubMed ID: 22109798
[TBL] [Abstract][Full Text] [Related]
22. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus.
Brunner HI; Gladman DD; Ibañez D; Urowitz MD; Silverman ED
Arthritis Rheum; 2008 Feb; 58(2):556-62. PubMed ID: 18240232
[TBL] [Abstract][Full Text] [Related]
23. Diffuse proliferative glomerulonephritis does not determine the worst outcome in childhood-onset lupus nephritis: a 23-year experience in a single centre.
Vachvanichsanong P; Dissaneewate P; McNeil E
Nephrol Dial Transplant; 2009 Sep; 24(9):2729-34. PubMed ID: 19395731
[TBL] [Abstract][Full Text] [Related]
24. Prognostic indicators of hospitalized patients with systemic lupus erythematosus: a large retrospective multicenter study in China.
Feng X; Zou Y; Pan W; Wang X; Wu M; Zhang M; Tao J; Zhang Y; Tan K; Li J; Chen Z; Ding X; Qian X; Da Z; Wang M; Sun L
J Rheumatol; 2011 Jul; 38(7):1289-95. PubMed ID: 21459949
[TBL] [Abstract][Full Text] [Related]
25. Clinical and immunological manifestations of systemic lupus erythematosus: study on 146 south Tunisian patients.
Jallouli M; Frigui M; Hmida MB; Marzouk S; Kaddour N; Bahloul Z
Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):1001-8. PubMed ID: 18974596
[TBL] [Abstract][Full Text] [Related]
26. Prevalence, predictors and outcome of vascular damage in systemic lupus erythematosus.
Becker-Merok A; Nossent J
Lupus; 2009 May; 18(6):508-15. PubMed ID: 19395452
[TBL] [Abstract][Full Text] [Related]
27. Summarizing disease features over time: II. Variability measures of SLEDAI-2K.
Ibañez D; Gladman D; Urowitz M
J Rheumatol; 2007 Feb; 34(2):336-40. PubMed ID: 17183620
[TBL] [Abstract][Full Text] [Related]
28. The clinical manifestations and survival of systemic lupus erythematosus patients in Turkey: report from two centers.
Pamuk ON; Akbay FG; Dönmez S; Yilmaz N; Calayir GB; Yavuz S
Lupus; 2013 Nov; 22(13):1416-24. PubMed ID: 23929639
[TBL] [Abstract][Full Text] [Related]
29. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992.
Uramoto KM; Michet CJ; Thumboo J; Sunku J; O'Fallon WM; Gabriel SE
Arthritis Rheum; 1999 Jan; 42(1):46-50. PubMed ID: 9920013
[TBL] [Abstract][Full Text] [Related]
30. The incidence and prevalence of systemic lupus erythematosus in Thrace, 2003-2014: A 12-year epidemiological study.
Pamuk ON; Balci MA; Donmez S; Tsokos GC
Lupus; 2016 Jan; 25(1):102-9. PubMed ID: 26345673
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism.
Gonzalez-Lopez L; Gamez-Nava JI; Jhangri GS; Ramos-Remus C; Russell AS; Suarez-Almazor ME
J Rheumatol; 1999 Mar; 26(3):540-5. PubMed ID: 10090159
[TBL] [Abstract][Full Text] [Related]
32. Systemic lupus erythematosus in a multiethnic US cohort. XXXIII. Clinical [corrected] features, course, and outcome in patients with late-onset disease.
Bertoli AM; Alarcón GS; Calvo-Alén J; Fernández M; Vilá LM; Reveille JD;
Arthritis Rheum; 2006 May; 54(5):1580-7. PubMed ID: 16645994
[TBL] [Abstract][Full Text] [Related]
33. [Systemic lupus erythematosus in men--a different prognosis?].
Specker C; Becker A; Lakomek HJ; Bach D; Grabensee B
Z Rheumatol; 1994; 53(6):339-45. PubMed ID: 7871906
[TBL] [Abstract][Full Text] [Related]
34. [Survival and prognostic factors of death risk in antiphospholipid syndrome: results of 8-year follow-up].
Reshetniak TM; Alekberova ZS; Kotel'nikova GP; Aleksandrova EN; Mach ES; Radenska-Lopovok SG; Kalashnikova LA; Nasonova VA
Ter Arkh; 2003; 75(5):46-51. PubMed ID: 12847898
[TBL] [Abstract][Full Text] [Related]
35. Association between serum total cholesterol level and renal outcome in systemic lupus erythematosus.
Tisseverasinghe A; Lim S; Greenwood C; Urowitz M; Gladman D; Fortin PR
Arthritis Rheum; 2006 Jul; 54(7):2211-9. PubMed ID: 16802357
[TBL] [Abstract][Full Text] [Related]
36. [Systemic lupus erythematosus: a clinical and immunological study of 300 patients].
Font J; Pallarés L; Cervera R; Vivancos J; López-Soto A; Herrero C; Darnell A; Torras A; Mirapeix E; del Olmo JA
Med Clin (Barc); 1993 Apr; 100(16):601-5. PubMed ID: 8497156
[TBL] [Abstract][Full Text] [Related]
37. Paediatric systemic lupus erythematosus: prognostic impact of antiphospholipid antibodies.
Descloux E; Durieu I; Cochat P; Vital Durand D; Ninet J; Fabien N; Cimaz R
Rheumatology (Oxford); 2008 Feb; 47(2):183-7. PubMed ID: 18160418
[TBL] [Abstract][Full Text] [Related]
38. Predictors of damage progression in Portuguese patients with systemic lupus erythematosus.
Santos MJ; Vinagre F; Nero P; Barcelos F; Barcelos A; Rodrigues AM; de Matos AA; Silva C; Miranda L; Capela S; Marques A; Branco J; da Silva JC
Ann N Y Acad Sci; 2009 Sep; 1173():822-8. PubMed ID: 19758234
[TBL] [Abstract][Full Text] [Related]
39. Associations of clinical features and prognosis with age at disease onset in patients with systemic lupus erythematosus.
Feng X; Zou Y; Pan W; Wang X; Wu M; Zhang M; Tao J; Zhang Y; Tan K; Li J; Chen Z; Ding X; Qian X; Da Z; Wang M; Sun L
Lupus; 2014 Mar; 23(3):327-34. PubMed ID: 24297642
[TBL] [Abstract][Full Text] [Related]
40. Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosus.
Nossent J; Kiss E; Rozman B; Pokorny G; Vlachoyiannopoulos P; Olesinska M; Marchesoni A; Mosca M; Påi S; Manger K; Schneider M; Nielsen H; van Vollenhoven R; Swaak T
Lupus; 2010 Jul; 19(8):949-56. PubMed ID: 20375124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
